Back to search
FDAFDA · Food and drugs·Recall number D-0867-2017

LaBri's Body Health Atomic, 60 capsules

Published May 31, 2017 · Recall initiated: March 28, 2017

Summary

FDA records drug Class I recall D-0867-2017, published May 31, 2017 and initiated March 28, 2017. Recalling firm: Envy Me; Status: Terminated; Reported quantity: unknown; Lot: All lot codes, manufacturing codes and expiration dates. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an approved NDA/ANDA: Product contains undeclared Sibutramine.

What to do

Voluntary: Firm initiated · Other

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Envy Me
Distributor
Product sold nationwide through internet sales. No foreign consignees were reported.
Lot
All lot codes, manufacturing codes and expiration dates.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was LaBri's Body Health Atomic, 60 capsules recalled?

Yes. FDA published recall D-0867-2017 on May 31, 2017. Reported hazard: Marketed without an approved NDA/ANDA: Product contains undeclared Sibutramine.

What should I do if I have this product?

Voluntary: Firm initiated · Other